Everand Logo

Welcome to Everand!

  • STAT

    Oprah 2020: Science is not her secret

    She's built an empire on feel good and health claims. But Oprah pushes some pretty shady science.
    by Megan Thielking Jan 09, 2018 4 minutes
    Dr. Mehmet Oz and host Oprah Winfrey react to seeing Dr. Phil McGraw with his mustache shaved off during "The Oprah Winfrey Show" in 2010.

    Oprah is beloved. Her fans love her. Stedman loves her. Even President Trump loves her.

    The science community does not love her.

    Oprah Winfrey has had indisputable influence over public health knowledge. Millions of people watched Winfrey every day for decades. She has a monthly magazine with her face on the cover. She has had a cable television channel, a satellite radio station, and a sweeping online presence. But at times, Winfrey has given a platform to people who promote medical treatments and health advice that aren’t based in evidence.

    Now, amid mostly theoretical talk of a possible 2020 presidential run for Winfrey, she analysis says. She promoted charlatans on her show, according to . Former Arkansas governor Mike Huckabee put out a Tuesday attacking Winfrey for “giving a platform to anti-vaccination campaigners and other dangerous health quackery.”

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
    A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About BIO’s China Challenge, Zepbound Shortages, And More
    BIO's about-face in its relationship with WuXi AppTec illustrates the difficulty the biotech industry faces in dealing with an issue that is moving fast and forcefully.
    STAT1 min read
    Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
    To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

    Related Books & Audiobooks